ARCHIVES

NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978

NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research

October 15, 1999

Decision Network Votes 14-11 for Laetrile Testing

September 29, 1978

Committee Approves Concepts For Studies In Special Populations

December 11, 1987

Komen Officials Say Charity is Stabilizing Despite 22 Percent Drop in Contributions

January 24, 2014

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010